The effects of denosumab on cortical bone parameters at the hip and their clinical relevance in women with postmenopausal osteoporosis aged <75 and ≥75 years

被引：0
|
作者：
Genant, H. K. [1 ,2 ]
Keaveny, T. M. [3 ,4 ]
Zapalowski, C. [5 ]
Engelke, K. [2 ]
Fuerst, T. [2 ]
Kendler, D. L. [6 ]
Recknor, C. [7 ]
Boonen, S. [8 ]
Wang, A. [5 ]
Dakin, P. [5 ]
Libanati, C. [5 ]
McClung, M. R. [9 ]
机构：
[1] USCF, San Francisco, CA USA
[2] Synarc Inc, San Francisco, CA USA
[3] Univ Calif Berkeley, Berkeley, CA USA
[4] ON Diagnost, Berkeley, CA USA
[5] Amgen Inc, Thousand Oaks, CA 91320 USA
[6] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[7] United Osteoporosis Ctr, Gainesville, GA USA
[8] Leuven Univ, Leuven, Belgium
[9] Oregon Osteoporosis Ctr, Portland, OR USA
来源：
AUSTRALASIAN JOURNAL ON AGEING | 2014年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
FP17
引用
收藏
页码：59 / 59
页数：1
相关论文
共 50 条
  • [1] Cortical Bone Parameters at the Hip in Response to Denosumab vs Placebo and the Clinical Relevance of These Changes in Postmenopausal Women With Osteoporosis <75 and ≥75 Years Old
    Genant, Harry K.
    Keaveny, Tony M.
    Zapalowski, Carol
    Engelke, Klaus
    Fuerst, Thomas
    Kendler, David L.
    Recknor, Christopher
    Boonen, Steven
    Wang, Andrea
    Dakin, Paula
    Libanati, Cesar
    McClung, Michael R.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28
  • [2] CLINICAL RELEVANCE OF CHANGES IN HIP CORTICAL BONE PARAMETERS IN RESPONSE TO DENOSUMAB (DMAB) VS. PLACEBO (PBO) IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS &lt;75 AND ≥75 YEARS OLD
    Genant, H. K.
    Keaveny, T. M.
    Zapalowski, C.
    Engelke, K.
    Fuerst, T.
    Kendler, D. L.
    Recknor, C.
    Boonen, S.
    Wang, A.
    Dakin, P.
    Libanati, C.
    Mcclung, M. R.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 : S175 - S175
  • [3] Low incidence of fracture maintained with long-term denosumab treatment in women aged ≥75 years with postmenopausal osteoporosis
    Papapoulos, S.
    McClung, M. R.
    Ranchimont, N.
    Adachi, J. D.
    Bone, H. G.
    Benhamou, C. L.
    Farrerons, J.
    Halse, J.
    Lippuner, K.
    Man, Z.
    Minisola, S.
    Torring, O.
    Daizadeh, N.
    Wang, A.
    Wagman, R. B.
    Boonen, S.
    AUSTRALASIAN JOURNAL ON AGEING, 2013, 32 : 23 - 23
  • [4] DENOSUMAB (DMAB) TREATMENT FOR 6 YEARS MAINTAINS LOW FRACTURE INCIDENCE IN WOMEN ≥75 YEARS WITH POSTMENOPAUSAL OSTEOPOROSIS (PMO)
    Papapoulos, Socrates
    Mcclung, Michael R.
    Franchimont, Nathalie
    Adachi, Jonathan D.
    Bone, Henry G.
    Benhamou, Claude-Laurent
    Farrerons, Jordi
    Gallagher, John Christopher
    Halse, Johan
    Lippuner, Kurt
    Man, Zulema
    Minisola, Salvatore
    Torring, Ove
    Daizadeh, Nadia
    Wang, Andrea
    Wagman, Rachel B.
    Boonen, Steven
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 : S45 - S46
  • [5] Low Fracture Incidence Is Maintained in Postmenopausal Women ≥75 Years with Osteoporosis with Long-Term Denosumab Treatment.
    Papapoulos, Socrates
    McClung, Michael R.
    Franchimont, Nathalie
    Adachi, Jonathan D.
    Bone, Henry G.
    Benhamou, Claude-Laurent
    Farrerons, Jordi
    Gallagher, J. C.
    Halse, Johan
    Lippuner, Kurt
    Minisola, Salvatore
    Toerring, Ove
    Daizadeh, Nadia
    Wang, Andrea
    Wagman, Rachel B.
    Boonen, Steven
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S830 - S831
  • [6] Comparative clinical outcomes of mechanical circulatory support in adults aged ≥75 years versus &lt;75 years
    Batra, J.
    Itagaki, S.
    Toyoda, N.
    Chikwe, J.
    Egorova, N. N.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2016, 64 : S148 - S149
  • [7] Bone mineral density in women aged 75 years or older
    Almeida, TLC
    Silva, MV
    Modesto, TCC
    Modesto, J
    Fonseca, GM
    OSTEOPOROSIS INTERNATIONAL, 2004, 15 : S68 - S68
  • [8] Effects of denosumab on bone density, mass and strength in women with postmenopausal osteoporosis
    Torring, Ove
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2015, 7 (03) : 88 - 102
  • [9] DENOSUMAB INCREASES TOTAL HIP BONE MINERAL DENSITY IN OLDER WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS
    Boonen, S.
    Miller, P. D.
    Lewiecki, E. M.
    Brandi, M. L.
    Adachi, J. D.
    Recknor, C.
    Wang, A.
    Hall, J. W.
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S248 - S249
  • [10] Denosumab increases total, trabecular, and cortical estimated hip and spine strength in postmenopausal women with osteoporosis
    Genant, H. K.
    Zanchetta, J. R.
    Kendler, D.
    Brown, J. P.
    Goemaere, S.
    Recknor, C.
    Brandi, M. L.
    Eastell, R.
    Kopperdahl, D.
    Engelke, K.
    Fuerst, T.
    Radcliffe, H. -S.
    Libanati, C.
    Keaveny, T.
    BONE, 2011, 48 : S86 - S87
12345